Published on 23 Jul 2023 on Simply Wall St. via Yahoo Finance
Arbutus Biopharma Corporation (NASDAQ:ABUS) has caught the attention of institutional investors who...
Key Insights
Institutions' substantial holdings in Arbutus Biopharma implies that they have significant influence over the company's share priceThe top 10 shareholders own 51% of the company Analyst forecasts along with ownership data serve to give a strong idea about prospects for a business
To get a sense of who is truly in control of Arbutus Biopharma Corporation (NASDAQ:ABUS), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 38% to be precise, is institutions. In other words, the group stands to gain the most (or lose the most) from their investment into the company.